Exploring Allogene's Q1 performance, strategic initiatives in oncology, and financial maneuvers amidst a challenging landscape.
Peraso Inc (PRSO) showcases a robust Q1 2024 performance with revenue growth and strategic advancements in mmWave technology.
Despite a revenue dip, Surgepays Inc boosts gross profit and cash reserves, while expanding its market reach through new partnerships and business verticals.